Uflex Ltd — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
UFlex reported consolidated revenue growth of 38% year-on-year to Rs. 53,972 million in Q1 FY27, with EBITDA rising 92% to Rs. 9,198 million and EBITDA margin expanding 480 basis points to 17%. Management attributed the growth to overseas operations in Egypt, Mexico and Nigeria along with the India PET chips business, higher realizations, currency tailwinds and pass-through of raw material costs. Management said the debt-to-EBITDA ratio improved from 4.5x to 3.5x during the quarter and outlined ongoing capex projects in Egypt, Mexico, Noida and Dharwad.
UFlex reported consolidated Q4 FY26 revenue of Rs.40,973 million, up 12.8% sequentially and 5.7% year-on-year, with EBITDA rising 36.3% QoQ and 31.8% YoY to Rs.6,265 million and EBITDA margin expanding to 15.3%, the highest in 14 quarters. For full year FY26, consolidated revenue grew 2.1% to Rs.155,130 million while EBITDA rose 8.1% to Rs.19,836 million with margin expanding 70 basis points to 12.8%. Management discussed capacity ramp-ups in Egypt and Mexico, capital expenditure plans, leverage trends, and regional demand across India, Americas, Europe and the Middle East and Africa.